Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The rules of grant writing

Prof Alex Adjei - Cleveland Clinic, Cleveland, USA
The rules of grant writing ( Prof Alex Adjei - Cleveland Clinic, Cleveland, USA )
21 Dec 2023

Zanidatamab, palbociclib and fulvestrant show positive results in treating HER2+/HR+ mBC

Dr Santiago Escrivá-de-Romani - Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Zanidatamab, palbociclib and fulvestrant show positive results in treating HER2+/HR+ mBC ( Dr Santiago Escrivá-de-Romani - Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain )
20 Dec 2023

Toripalimab and metronomic chemotherapy show efficacy in treating in HER2-negative metastatic breast cancer

Dr Hongnan Mo - National Cancer Center/Cancer Hospital, Beijing, China
Toripalimab and metronomic chemotherapy show efficacy in treating in HER2-negative metastatic breast cancer ( Dr Hongnan Mo - National Cancer Center/Cancer Hospital, Beijing, China )
20 Dec 2023

Beat AML master trial: A clinical trial for acute myeloid leukaemia

Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA
Beat AML master trial: A clinical trial for acute myeloid leukaemia ( Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA )
20 Dec 2023

Introducing oncology to undergraduate medical and allied health sciences students

Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India
Introducing oncology to undergraduate medical and allied health sciences students ( Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India )
8 Dec 2023

Cancer care in Needle Hospital, Hargeisa, Somaliland

Gebrekirstos Hagos - Needle Hospital, Hargeisa, Somaliland
Cancer care in Needle Hospital, Hargeisa, Somaliland ( Gebrekirstos Hagos - Needle Hospital, Hargeisa, Somaliland )
5 Dec 2023

First-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for R/M cervical cancer

Dr Ana Oaknin - Vall d´Hebron Institute of Oncology, Barcelona, Spain
First-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for R/M cervical cancer ( Dr Ana Oaknin - Vall d´Hebron Institute of Oncology, Barcelona, Spain )
4 Dec 2023

Special issue on real world breast cancer data

Dr Siddhartha Kar - University of Cambridge, Cambridge, UK
Special issue on real world breast cancer data ( Dr Siddhartha Kar - University of Cambridge, Cambridge, UK )
21 Nov 2023

Trial investigates multiparametric prognostic score in early HR+/HER2- breast cancer

Dr Oleg Gluz - Krankenhaus Bethesda, Mönchengladbach, Germany
Trial investigates multiparametric prognostic score in early HR+/HER2- breast cancer ( Dr Oleg Gluz -  Krankenhaus Bethesda, Mönchengladbach, Germany )
21 Nov 2023

Cabozantinib shows clinically meaningful improvement in advanced neuroendocrine tumours

Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA
Cabozantinib shows clinically meaningful improvement in advanced neuroendocrine tumours ( Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA )
7 Nov 2023

Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer

Prof Ignace Vergote - UZ Leuven, Leuven, Belgium
Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer ( Prof Ignace Vergote - UZ Leuven, Leuven, Belgium )
7 Nov 2023

CAR-T therapy and impact to cancer patient outcomes and experience of treatment

Mr Matthias Hellberg-Naegele - Cantonal Hospital St Gallen, St Gallen, Switzerland
CAR-T therapy and impact to cancer patient outcomes and experience of treatment ( Mr Matthias Hellberg-Naegele - Cantonal Hospital St Gallen, St Gallen, Switzerland )
7 Nov 2023